Clinical Scorecard: Musings from The Power List: Edward Sisco

At a Glance

Key Highlights

• Research aims to provide timely, comprehensive insights into the makeup of the illicit drug supply.
• Developed workflows can provide data to partners in hours rather than weeks or months.
• Results can prompt conversations about what a person is consuming, potential risks, and strategies to stay safe.
• The researcher describes standardized methods across laboratories as important for building larger data pools.

Guideline-Based Recommendations

Diagnosis

• The article describes research using chemical measurements to identify substances in samples and measure their concentrations.

Management

• The researcher says results shared with partners can prompt conversations about consumption, potential risks, and strategies to stay safe.

Monitoring & Follow-up

• The research tracks substances in the supply, their concentrations, where they occur, and where they originated; the team also tries to predict where substances may move next.

Risks

• The article discusses assessing potential harm relative to other samples but does not provide individual risk estimates, treatment protocols, or clinical recommendations.

Patient & Prescribing Data

The article describes sample analysis and partner collaborations but does not specify a patient population or provide prescribing or demographic data.

The researcher says sample results can prompt conversations about consumption, potential risks, and strategies to stay safe.

Clinical Best Practices

• The researcher describes sharing timely chemical-analysis data with partners to inform public health, public safety, and policy.
• The researcher says results can prompt conversations about what a person is consuming, potential risks, and strategies to stay safe.
• The researcher identifies standardized methods across laboratories as important for building larger data pools.

Related Resources & Content

• Article: Musings from The Power List: Edward Sisco